Financial Ratios

DISHMAN CARBOGEN AMCIS LTD.

NSE : DCALBSE : 540701ISIN CODE : INE385W01011Industry : Pharmaceuticals & DrugsHouse : Dishman Pharma
BSE176.10-5.7 (-3.14 %)
PREV CLOSE ( ) 181.80
OPEN PRICE ( ) 180.00
BID PRICE (QTY) 176.05 (100)
OFFER PRICE (QTY) 176.40 (108)
VOLUME 26079
TODAY'S LOW / HIGH ( )175.50 180.85
52 WK LOW / HIGH ( )129 321.15
NSE176.00-5.41 (-2.98 %)
PREV CLOSE( ) 181.41
OPEN PRICE ( ) 180.50
BID PRICE (QTY) 176.00 (150)
OFFER PRICE (QTY) 176.26 (62)
VOLUME 220944
TODAY'S LOW / HIGH( ) 175.31 180.85
52 WK LOW / HIGH ( )128.5 321.95
Select year
ParticularsMar2025Mar2024Mar2023Mar2022Mar2021
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.63-4.87-3.75-1.94-14.42
   CEPS(Rs)3.531.612.386.99-5.41
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)257.05258.46262.39269.88298.13
   Tax Rate(%)67.9925.8238.8063.43-39.58
Margin Ratios
   Core EBITDA Margin(%)17.952.081.9311.02-26.35
   EBIT Margin(%)9.90-10.63-9.51-15.03-63.82
   Pre Tax Margin(%)-7.71-31.46-23.90-27.17-80.88
   PAT Margin (%)-2.47-23.34-14.62-9.94-112.89
   Cash Profit Margin (%)13.847.709.2735.75-42.33
Performance Ratios
   ROA(%)-0.19-1.45-1.10-0.55-3.90
   ROE(%)-0.24-1.87-1.41-0.68-4.78
   ROCE(%)0.85-0.75-0.81-0.93-2.42
   Asset Turnover(x)0.080.060.080.060.03
   Sales/Fixed Asset(x)0.150.130.170.130.09
   Working Capital/Sales(x)17.48-10.3950.261.431.04
Efficiency Ratios
   Fixed Capital/Sales(x)6.507.685.967.6711.75
   Receivable days163.61184.2696.32109.85240.32
   Inventory Days138.70196.40172.08226.96362.63
   Payable days261.71316.66148.22198.71262.47
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)61.67146.6052.3826.49-20.16
   Price/Book(x)0.850.910.480.690.37
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)10.0112.866.1510.9110.76
   EV/Core EBITDA(x)38.2160.2541.3333.47159.63
   EV/EBIT(x)101.17-120.89-64.70-72.56-16.86
   EV/CE(x)0.850.920.530.700.41
   M Cap / Sales8.5311.294.869.478.53
Growth Ratio
   Net Sales Growth(%)22.14-18.6831.2953.06-65.51
   Core EBITDA Growth(%)49.9916.57-40.02640.00-94.45
   EBIT Growth(%)213.679.0616.9363.96-224.76
   PAT Growth(%)87.08-29.79-93.2186.53-687.07
   EPS Growth(%)87.08-29.79-93.2186.53-687.44
Financial Stability Ratios
   Total Debt/Equity(x)0.170.130.140.120.11
   Current Ratio(x)1.040.951.011.391.36
   Quick Ratio(x)0.830.670.731.031.01
   Interest Cover(x)0.56-0.51-0.66-1.24-3.74
   Total Debt/Mcap(x)0.200.140.300.180.31

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.